Journals / Eurasian Journal of Medicine / 2017 / Cilt: 49 - Sayı: 2

Ovarian Endometriomalı Kadınlarda Ki-67 Proliferasyon İndeksi ve Urokortinin Değerlendirilmesi

Evaluation of the Ki-67 Proliferation Index and Urocortin Expression in Women with Ovarian Endometriomas

Pages
107–112
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A statistically significant difference was determined between postoperative CA125 median levels of patients without recurrence (10±17.6) and those of patients with recurrence (29.9±18.1) (p=0.003).Conclusion: The Ki-67 proliferation index may be useful for predicting prognosis and recurrence risk

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The reasons why endometriosis is more aggressive and invasive in some patients are unknown.
📊
Key Findings & Data:Therefore, the discovery of significant potential biomarkers could be useful to clinicians for shedding light on the pathogenesis of endometriosis and in the monitoring recurrence.Materials and Methods: This study included 50 patients who underwent surgery for ovarian cysts that were diagnosed as endometrioma.
💡
Conclusion & Impact:A statistically significant difference was determined between postoperative CA125 median levels of patients without recurrence (10±17.6) and those of patients with recurrence (29.9±18.1) (p=0.003).Conclusion: The Ki-67 proliferation index may be useful for predicting prognosis and recurrence risk
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The reasons why endometriosis is more aggressive and invasive in some patients are unknown. Despite the importance of population-based clinically defined risk factors in the prediction of recurrence, biochemical markers obtained from the patient are more valuable for prediction on an individual basis. Therefore, the discovery of significant potential biomarkers could be useful to clinicians for shedding light on the pathogenesis of endometriosis and in the monitoring recurrence.Materials and Methods: This study included 50 patients who underwent surgery for ovarian cysts that were diagnosed as endometrioma. The age of the patients, stage of the endometriosis, diameter and localization of endometriomas, type of surgery, and pre- and postoperative cancer antigen 125 (CA125) levels were compared between patients with and without recurrence. The archived pathology slides were stained with Ki-67 and anti-urocortin antibodies for reevaluation. By comparing the pathology parameters of the patients with and without recurrence, the association between these parameters and recurrence was investigated. Results: The median Ki-67 proliferation index of the patients with recurrence (7.5±6.5) was statistically significant compared with that of the patients without recurrence (1±4) (p=0.003). The urocortin epithelial staining intensity and percentage were not found to be statistically significant in comparison. A statistically significant difference was determined between postoperative CA125 median levels of patients without recurrence (10±17.6) and those of patients with recurrence (29.9±18.1) (p=0.003).Conclusion: The Ki-67 proliferation index may be useful for predicting prognosis and recurrence risk

Özet

Amaç: Endometriozisin bazı hastalarda neden daha agresif ve invaziv olduğunun nedenleri bilinmemektedir. Klinik olarak belirlenen risk faktörleri populasyon bazında rekürrens prediksiyonunda değerli olmasına rağmen kişi bazında prediksiyonda hastadan elde edilen biyokimyasal markerlar daha değerlidir. Bu nedenle, rekürrens açısından anlamlı potansiyel biyomarkerların keşfi endomeriozis patogenezine ışık tutabileceği gibi rekürrens takibinde klinisyenlere yardımcı bir parametre olarak kullanılabilir.Gereç ve Yöntem: Çalışmamıza over kisti nedeniyle cerrahi geçiren ve patolojik inceleme sonucunda endometrioma tanısı konmuş 50 hasta dahil edildi. Olguların yaş, endometriozis evresi, endometrioma çapı ve lokalizasyonu, cerrahi tipi, preoperatif ve postoperatif CA 125 düzeyleri kaydedildi. Olguların arşiv patoloji preparatları Ki 67 ve anti-urocortin antikor ile boyandı. Patolojik parametreler nüks olan olgular ile olmayanlarda kıyaslanarak bu parametrelerin rekürrens ile ilişkisi araştırıldı.Bulgular: Nüks olan olguların Ki67 İndeks medyanı (7,5±6,5) nüks olmayan olguların Ki67 İndeks medyan değerinden (1±4) daha büyük olup, istatistiksel olarak anlamlıydı (p=0,003). Olguların nüks olma durumu ile ürocortin epitel boyanma yoğunluğu ve yüzdesine göre dağılımı ise istatistiksel olarak anlamlı değildi. Nüks olmayan olguların postoperatif CA 125 medyan değeri (10±17,6) nüks olan olguların CA 125 medyan değerinden (29,9±18,1) daha küçük olup bu istatistiksel olarak anlamlıydı (p=0,003).Sonuç: Ki67 proliferasyon indeksi prognoz ve rekürrens riskini predikte etmede yardımcı bir belirteç olabilir

🔖

Cite This Article

CALTEKİN, M. D., AYDOGMUS, H., YALCİN, Y., SELİM, H. S., YALCİN, S. E., OCAL, I., KELEKCİ, S. (2022). Ovarian Endometriomalı Kadınlarda Ki-67 Proliferasyon İndeksi ve Urokortinin Değerlendirilmesi. Eurasian Journal of Medicine, Cilt: 49 - Sayı: 2, 107–112. https://ajindex.com/articles/509027

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Bhanoori M, Arvind Babu K, Pavankumar Reddy NG, et al. The vascular endothelial growth factor (VEGF) +405G>C 5’-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study. Hum Reprod 2005; 20: 1844-9
  2. Kim SH, Choi YM, Choung SH, Jun JK, Kim JG, Moon SY. Vascular endothelial growth factor gene +405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis. Hum Reprod 2005; 20: 2904-8
  3. Huisman MA, De Heer E, Grote JJ. Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis. Acta Otolaryngol 2003; 123: 377-82
  4. Dahmoun M, Boman K, Cajander S, Westin P, Backström T. Apoptosis, proliferation, and sex hormone receptors in superficial parts of human endometrium at the end of the secretory phase. J Clin Endocrinol Metab 1999; 84: 1737-43
  5. Park JS, Lee JH, Kim M, Chang HJ, Hwang KJ, Chang KH. Endometrium from women with endometriosis shows increased proliferation activity. Fertil Steril 2009; 92: 1246-9
  6. Vaughan J, Donaldson C, Bittencourt J, et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995: 378; 287-92
  7. Reyes TM, Lewis K, Perrin MH, et al. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci U S A 2001; 27: 2843-8
  8. Lewis K, Li C, Perrin MH, et al. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A 2001; 19: 7570-5
  9. Agnello D, Bertini R, Sacco S, Meazza C, Villa P, Ghezzi P. Corticosteroid-independent inhibition of tumor necrosis factor production by the neuropeptide urocortin. Am J Physiol 1998; 275: E757-62
  10. Florio P, Arcuri F, Ciarmela P, et al. Identification of urocortin mRNA and peptide in the human endometrium. J Endocrinol 2002; 173: R9-14
  11. Torricelli M, De Falco G, Florio P, et al. Secretory endometrium highly expresses urocortin messenger RNA and peptide: possible role in the decidualization process. Hum Reprod 2007; 22: 92-6
  12. Hao Z, Huang Y, Cleman J, et al. Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferation. Proc Natl Acad Sci U S A 2008; 105: 3939-44
  13. Toki T, Kubota J, Lu X, Nakayama K. Immunohistochemical analysis of CA125, CA19-9, and Ki-67 in stage